UPDATE: Danaher Q4 Revenues Rise 38 Percent on Life Sciences & Diagnostics Growth | GenomeWeb

The story has been updated to include comments made by company executives during a conference call.

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Danaher today reported a 38 percent increase in its fourth-quarter revenues as its Life Sciences & Diagnostics segment more than doubled its sales.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: role for epigenetic in neuronal excitability, and more.

The new Office of Research Integrity director is grappling with complaints from her staff, according to ScienceInsider.

Italian researchers link SNPs in the PDSS2 gene to coffee consumption in a new paper.

A gene-editing ban has been interpreted to include mitochondrial transfer, Technology Review reports.